Linked Life Data

15187780

Source:http://linkedlifedata.com/resource/pubmed/id/15187780

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2004-6-9
pubmed:abstractText
The purpose of this study was to describe the clinical experience with the anti-tumor necrosis factor chimeric monoclonal antibody, infliximab, in pediatric patients with Crohn disease in The Netherlands.
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
0277-2116
pubmed:author
pubmed:issnType
Print
pubmed:volume
39
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
46-52
pubmed:meshHeading
pubmed:year
2004
pubmed:articleTitle
Infliximab therapy in 30 patients with refractory pediatric crohn disease with and without fistulas in The Netherlands.
pubmed:affiliation
Emma Children's Hospital/Academic Medical Centre, Amsterdam, The Netherlands. l.deridder@amc.uva.nl
pubmed:publicationType
Journal Article